MedPath

Evaluate the efficacy of Arjunadi lepa and Naturopathy based face mud pack in vyanga.

Phase 2
Not yet recruiting
Conditions
Chloasma. Ayurveda Condition: VYANGAH,
Registration Number
CTRI/2022/06/042971
Lead Sponsor
National Institute of Ayurveda
Brief Summary

Need of study :

In modern allopathy medicines many topical steroid ointments are prescribed in the management of melasma.

However, many such ointments cause adverse effect such as irritation, rashes etc.

So a natural herbal based Ayurvedic or naturopathic facepack can be a safe, cost effective and better treatment.

 AIM and OBJECTIVE :

The aim of this study is to evaluate the effect of Arjunadi lepa and naturopathy based face mudpack in management of vyanga. RESEARCH QUESTION :

1.      Does Arjunadi lepa have any effect in vyanga?

2.      Does naturopathy face mudpack have any effect on vyanga?

3.      Whether the effect of Arjunadi lepa is more or less as compared to naturopathy based face mudpack in management of vyanga?

HYPOTHESIS :

Null hypothesis ( Ho )

There is no difference between the effect of Arjunadi lepa and naturopathy based mudpack in management of vyanga.

Research hypothesis ( H1 )

There is significant difference between the effect of Arjunadi lepa and naturopathy based mudpack in management of vyanga.

Detailed Description

Not available

Recruitment & Eligibility

Status
Not Yet Recruiting
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Patients suffering from classical clinical signs and symptoms of Vyanga 2.
  • Patient of age 20 to 40 years irrespective of sex and religion.
Exclusion Criteria
  • 1.Patients receiving hormone or corticosteroid therapy 2.Patients with history of endocrine disorders or allergies.
  • 3.Patients taking depigmenting or whitening products (oral or topical) within the previous 6 weeks.
  • 4.Pregnant or breast feeding mother 5.Subjects who are allergic to chemical compound in the Lepa or fragrance.
  • 6.Using a medication that increases sensitivity to sunlight including doxycycline, minocycline, tetracycline, ciprofloxin, hydrochlorothiazide, and sulfonamides.
  • 7.Usage of any new skincare products during the course of the study.
  • 8.Facial/laser treatment within the last 3 months 9.Facial cosmetic surgery within the last 12 months 10.Physical skin conditions such as excessive hair, scarring, tattoos that might impair evaluations of the test sites.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Change in Melasma Area and Severity Index (MASI) Score8 weeks
Severity of melasma in each of the four regions (forehead, right malar region, left malar region and chin) is assessed on percentage of the total area involved (A), darkness (D), and homogeneity (H).8 weeks
Secondary Outcome Measures
NameTimeMethod
1. Color assessment of facial hyperpigmentation2. Patients Global Assessment of facial hyperpigmentation

Trial Locations

Locations (1)

National Institute of Ayurveda

🇮🇳

Jaipur, RAJASTHAN, India

National Institute of Ayurveda
🇮🇳Jaipur, RAJASTHAN, India
Dr Suman Bhamu
Principal investigator
9413234905
drsumanbhamu333@gmail.com

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.